The end of beta blockers for uncomplicated hypertension?

Affiliations

Comment

D Gareth Beevers. Lancet. 2005.

. 2005;366(9496):1510-2.

doi: 10.1016/S0140-6736(05)67575-7.

¹ University Department of Medicine, City Hospital, Birmingham B18 7QH, UK. ruby.stone@swbh.nhs.uk

No abstract available

Comment in

Beta blockers for the treatment of primary hypertension.
Khan N, McAlister FA. Khan N, et al. Lancet. 2006 Jan 21;367(9506):208; author reply 210. doi: 10.1016/S0140-6736(06)68027-6. Lancet. 2006. PMID: 16427485 No abstract available.
Beta blockers for the treatment of primary hypertension.
Ball SG. Ball SG. Lancet. 2006 Jan 21;367(9506):209-10; author reply 210. doi: 10.1016/S0140-6736(06)68029-X. Lancet. 2006. PMID: 16427486 No abstract available.
Beta blockers for the treatment of primary hypertension.
Cruickshank JM. Cruickshank JM. Lancet. 2006 Jan 21;367(9506):209; author reply 210. doi: 10.1016/S0140-6736(06)68028-8. Lancet. 2006. PMID: 16427487 No abstract available.

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.
Lindholm LH, Carlberg B, Samuelsson O. Lindholm LH, et al. Lancet. 2005 Oct 29-Nov 4;366(9496):1545-53. doi: 10.1016/S0140-6736(05)67573-3. Lancet. 2005. PMID: 16257341 Review.